Results 251 to 260 of about 39,513 (265)

BEANS—A SOURCE OF L-DOPA

The Lancet, 1969
openaire   +2 more sources

Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

Journal of Pineal Research, 2006
Rossana Migheli, Bianca Marchetti, Pier Andrea Serra   +2 more
exaly  

L-DOPA AND OCULOGYRIC CRISES

The Lancet, 1970
O W, Sacks, M, Kohl
openaire   +2 more sources

Interaction between l-DOPA and 3-O-methyl-l-DOPA for transport in immortalised rat capillary cerebral endothelial cells

Neuropharmacology, 1999
Pedro Gomes, Patricio Soares-Da-Silva
exaly  

Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis

Journal of Neurochemistry, 1993
Gabriel C Leger, Paul Cumming, Albert Gjedde   +2 more
exaly  

Side Effects of L-Dopa

New England Journal of Medicine, 1971
D S, Sax, D, Tarsy
openaire   +2 more sources

Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias

Experimental Neurology, 2010
Frank Schneider, Rylander Ottosson, Rudolf-Giesbert Alken   +2 more
exaly  

L Dopa

2007
openaire   +1 more source

Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa

Journal of Neurochemistry, 2006
Kenneth Rodgers, Roger T Dean, John G L Morris   +2 more
exaly  

Evidence for l-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat

Neuroscience Letters, 1992
Yoshio Goshima, Yuka Misu, Jin-Liang Yue   +2 more
exaly